Apellis Pharmaceuticals
APLS
APLS
129 hedge funds and large institutions have $973M invested in Apellis Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.6% less ownership
Funds ownership: 64% → 63.4% (-0.6%)
5% less capital invested
Capital invested by funds: $1.03B → $973M (-$52M)
Holders
129
Holding in Top 10
3
Calls
$9.03M
Puts
$462K
Top Buyers
| 1 | +$50.6M | |
| 2 | +$26.4M | |
| 3 | +$16.9M | |
| 4 |
Millennium Management
New York
|
+$16.1M |
| 5 |
Morgan Stanley
New York
|
+$9.64M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$28.9M | |
| 3 | -$16.3M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$11.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.2M |